Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 2Terminated 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Lymphoid 3Gastrointestinal 3Other hematologic neoplasm 2Tumor-Agnostic 1Thoracic 1Other 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Pain 1Neoplasms 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cisplatin 263Radiotherapy 166Cetuximab 159Docetaxel 105Fluorouracil 104pembrolizumab 94Radiotherapy, Intensity-Modulated 83Carboplatin 80Paclitaxel 73Nivolumab 59Erlotinib Hydrochloride 35Surveys and Questionnaires 32Gemcitabine 32durvalumab 30Radiation 29Drug Therapy 25Immunohistochemistry 21Gefitinib 21Capecitabine 21tremelimumab 18Bevacizumab 18Surgical Procedures, Operative 17Sorafenib 17Magnetic Resonance Spectroscopy 17Ipilimumab 17Pemetrexed 16lenvatinib 15atezolizumab 15Radiosurgery 15Gene Expression Profiling 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ketamine × Head & Neck × Clear all
NCT01653327 2018-09-28

Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer

Dartmouth-Hitchcock Medical Center

Phase 2 Completed
11 enrolled 5 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Pain, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡